Answers are grounded in this paper and cite their sources.
Narrative review reveals the development of pulmonary surfactant replacement in preterm neonates, highlighting intratracheal delivery as effective for restoring lung stability.
In 1959, not long after surfactant had been identified as critical to maintaining lung inflation at low transpulmonary pressures,1,2 Avery and Mead3 reported that saline extracts from the lungs of preterm infants with respiratory distress syndrome lacked the low surface tension characteristic of pulmonary surfactant. After several unsuccessful attempts to treat infants with respiratory distress syndrome with aerosolized surfactant,4,5 intratracheal administration of surfactant recovered from the air spaces of mature animal lungs was found to improve lung expansion and ventilation in preterm animals68. The clinical potential of surfactant treatment for respiratory distress syndrome was demonstrated by . . .
No takes yet. Share an insight, caveat, or question.
A 1993 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: